Term: | Lymphocytosis |
|
Accession: | HP:0100827
|
browse the term
|
Definition: | Increase in the number or proportion of lymphocytes in the blood. |
Synonyms: | exact_synonym: | High lymphocyte count |
| alt_id: | HP:0012141 |
| xref: | SNOMEDCT_US:67023009; UMLS:C0024282 |
|
|
|
G |
ARPC1B |
actin related protein 2/3 complex subunit 1B |
|
IAGP |
|
HPO |
|
MIM:617718 |
NCBI chr 7:99,374,259...99,394,816
Ensembl chr 7:99,374,249...99,394,816
|
|
G |
CASP10 |
caspase 10 |
|
IAGP |
|
HPO |
|
ORPHA:3261 |
NCBI chr 2:201,183,141...201,229,406
Ensembl chr 2:201,182,872...201,229,428
|
|
G |
CCR5 |
C-C motif chemokine receptor 5 |
|
IAGP |
DNA:deletion:cds: |
RGD |
PMID:10534150 |
RGD:14401730 |
NCBI chr 3:46,370,142...46,376,206
Ensembl chr 3:46,370,946...46,376,206
|
|
G |
EIF2AK3 |
eukaryotic translation initiation factor 2 alpha kinase 3 |
|
IAGP |
|
HPO |
|
ORPHA:1667 |
NCBI chr 2:88,556,741...88,628,145
Ensembl chr 2:88,556,741...88,691,518
|
|
G |
ELF4 |
E74 like ETS transcription factor 4 |
|
IAGP |
|
HPO |
|
MIM:301074 |
NCBI chr X:130,063,955...130,111,927
Ensembl chr X:130,063,955...130,110,716
|
|
G |
FAS |
Fas cell surface death receptor |
|
IAGP |
|
HPO |
|
ORPHA:3261 |
NCBI chr10:88,964,050...89,017,059
Ensembl chr10:88,953,813...89,029,605
|
|
G |
FASLG |
Fas ligand |
|
IAGP |
|
HPO |
|
ORPHA:3261 |
NCBI chr 1:172,659,103...172,666,876
Ensembl chr 1:172,659,103...172,666,876
|
|
G |
FOCAD |
focadhesin |
|
IAGP |
|
HPO |
|
MIM:619991 |
NCBI chr 9:20,655,625...20,995,950
Ensembl chr 9:20,658,309...20,995,955
|
|
G |
IL7R |
interleukin 7 receptor |
|
IAGP |
|
HPO |
|
ORPHA:169154 |
NCBI chr 5:35,856,891...35,879,603
Ensembl chr 5:35,852,695...35,879,603
|
|
G |
KRAS |
KRAS proto-oncogene, GTPase |
|
IAGP |
|
HPO |
|
MIM:614470 |
NCBI chr12:25,205,246...25,250,929
Ensembl chr12:25,205,246...25,250,936
|
|
G |
LMNB2 |
lamin B2 |
|
IAGP |
|
HPO |
|
ORPHA:79087 |
NCBI chr19:2,428,166...2,456,959
Ensembl chr19:2,427,638...2,456,959
|
|
G |
NRAS |
NRAS proto-oncogene, GTPase |
|
IAGP |
|
HPO |
|
MIM:614470 |
NCBI chr 1:114,704,469...114,716,771
Ensembl chr 1:114,704,469...114,716,771
|
|
G |
REL |
REL proto-oncogene, NF-kB subunit |
|
IAGP |
|
HPO |
|
MIM:619652 |
NCBI chr 2:60,881,574...60,931,612
Ensembl chr 2:60,881,491...60,931,612
|
|
G |
RNASEH2B |
ribonuclease H2 subunit B |
|
IAGP |
|
HPO |
|
MIM:610181 |
NCBI chr13:50,909,678...50,970,460
Ensembl chr13:50,909,747...51,024,120
|
|
G |
SH2D1A |
SH2 domain containing 1A |
|
IAGP |
|
HPO |
|
MIM:308240 |
NCBI chr X:124,346,563...124,373,160
Ensembl chr X:124,227,868...124,373,197
|
|
G |
XIAP |
X-linked inhibitor of apoptosis |
|
IAGP |
|
HPO |
|
MIM:308240 |
NCBI chr X:123,859,708...123,913,972
Ensembl chr X:123,859,712...123,913,972
|
|
G |
ZAP70 |
zeta chain of T cell receptor associated protein kinase 70 |
|
IAGP |
|
HPO |
|
ORPHA:911 |
NCBI chr 2:97,713,576...97,756,364
Ensembl chr 2:97,713,576...97,744,327
|
|
|
G |
CARD11 |
caspase recruitment domain family member 11 |
|
IAGP |
DNA:missense mutations:cds:p.E127G, p.G116S |
HPO RGD |
PMID:23129749 |
MIM:616452, RGD:11100033 |
NCBI chr 7:2,906,142...3,043,867
Ensembl chr 7:2,906,142...3,044,228
|
|
G |
CASP10 |
caspase 10 |
|
IAGP |
|
HPO |
|
MIM:603909 ORPHA:3261 |
NCBI chr 2:201,183,141...201,229,406
Ensembl chr 2:201,182,872...201,229,428
|
|
G |
FAS |
Fas cell surface death receptor |
|
IAGP |
|
HPO |
|
ORPHA:3261 |
NCBI chr10:88,964,050...89,017,059
Ensembl chr10:88,953,813...89,029,605
|
|
G |
FASLG |
Fas ligand |
|
IAGP |
|
HPO |
|
ORPHA:3261 |
NCBI chr 1:172,659,103...172,666,876
Ensembl chr 1:172,659,103...172,666,876
|
|
G |
IKBKG |
inhibitor of nuclear factor kappa B kinase regulatory subunit gamma |
|
IAGP |
|
HPO |
|
ORPHA:98813 |
NCBI chr X:154,541,238...154,565,046
Ensembl chr X:154,541,199...154,565,046
|
|
G |
LYN |
LYN proto-oncogene, Src family tyrosine kinase |
|
IAGP |
|
HPO |
|
MIM:620376 |
NCBI chr 8:55,879,835...56,014,169
Ensembl chr 8:55,879,835...56,014,169
|
|
G |
MAP3K14 |
mitogen-activated protein kinase kinase kinase 14 |
|
IAGP |
|
HPO |
|
MIM:620449 |
NCBI chr17:45,263,119...45,317,020
Ensembl chr17:45,263,119...45,317,029
|
|
G |
NCKAP1L |
NCK associated protein 1 like |
|
IAGP |
|
HPO |
|
MIM:618982 |
NCBI chr12:54,497,752...54,548,243
Ensembl chr12:54,497,752...54,548,243
|
|
G |
NFKBIA |
NFKB inhibitor alpha |
|
IAGP |
|
HPO |
|
ORPHA:98813 |
NCBI chr14:35,401,513...35,404,749
Ensembl chr14:35,401,079...35,404,749
|
|
G |
PRKCD |
protein kinase C delta |
|
IAGP |
|
HPO |
|
MIM:615559 |
NCBI chr 3:53,161,209...53,192,717
Ensembl chr 3:53,156,009...53,192,717
|
|
G |
PTPRC |
protein tyrosine phosphatase receptor type C |
|
IAGP |
|
HPO |
|
MIM:619924 |
NCBI chr 1:198,638,713...198,757,476
Ensembl chr 1:198,638,457...198,759,342
|
|
|
G |
BTNL2 |
butyrophilin like 2 |
|
IAGP |
|
HPO |
|
ORPHA:797 |
NCBI chr 6:32,393,339...32,407,181
Ensembl chr 6:32,393,339...32,407,181
|
|
G |
HLA-DRB1 |
major histocompatibility complex, class II, DR beta 1 |
|
IAGP |
|
HPO |
|
ORPHA:797 |
NCBI chr 6:32,578,775...32,589,848
Ensembl chr 6:32,577,902...32,589,848
|
|
G |
IKBKG |
inhibitor of nuclear factor kappa B kinase regulatory subunit gamma |
|
IAGP |
|
HPO |
|
ORPHA:98813 |
NCBI chr X:154,541,238...154,565,046
Ensembl chr X:154,541,199...154,565,046
|
|
G |
LYN |
LYN proto-oncogene, Src family tyrosine kinase |
|
IAGP |
|
HPO |
|
MIM:620376 |
NCBI chr 8:55,879,835...56,014,169
Ensembl chr 8:55,879,835...56,014,169
|
|
G |
MAP3K14 |
mitogen-activated protein kinase kinase kinase 14 |
|
IAGP |
|
HPO |
|
MIM:620449 |
NCBI chr17:45,263,119...45,317,020
Ensembl chr17:45,263,119...45,317,029
|
|
G |
NFKBIA |
NFKB inhibitor alpha |
|
IAGP |
|
HPO |
|
ORPHA:98813 |
NCBI chr14:35,401,513...35,404,749
Ensembl chr14:35,401,079...35,404,749
|
|
Term paths to the root
|